IRIDEX (IRIX) Competitors $1.73 -0.01 (-0.57%) (As of 11:30 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends IRIX vs. RMTI, TELA, FONR, GUTS, EDAP, LNSR, VANI, MODD, NSPR, and MGRMShould you be buying IRIDEX stock or one of its competitors? The main competitors of IRIDEX include Rockwell Medical (RMTI), TELA Bio (TELA), FONAR (FONR), Fractyl Health (GUTS), Edap Tms (EDAP), LENSAR (LNSR), Vivani Medical (VANI), Modular Medical (MODD), InspireMD (NSPR), and Monogram Orthopaedics (MGRM). IRIDEX vs. Rockwell Medical TELA Bio FONAR Fractyl Health Edap Tms LENSAR Vivani Medical Modular Medical InspireMD Monogram Orthopaedics Rockwell Medical (NASDAQ:RMTI) and IRIDEX (NASDAQ:IRIX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, community ranking, dividends, risk, media sentiment, institutional ownership, earnings, profitability and analyst recommendations. Is RMTI or IRIX more profitable? Rockwell Medical has a net margin of -1.25% compared to IRIDEX's net margin of -22.79%. Rockwell Medical's return on equity of 8.55% beat IRIDEX's return on equity.Company Net Margins Return on Equity Return on Assets Rockwell Medical-1.25% 8.55% 3.80% IRIDEX -22.79%-192.95%-33.97% Does the media prefer RMTI or IRIX? In the previous week, Rockwell Medical had 8 more articles in the media than IRIDEX. MarketBeat recorded 12 mentions for Rockwell Medical and 4 mentions for IRIDEX. Rockwell Medical's average media sentiment score of 0.39 beat IRIDEX's score of 0.11 indicating that Rockwell Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 2 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend RMTI or IRIX? Rockwell Medical presently has a consensus target price of $7.00, suggesting a potential upside of 208.37%. IRIDEX has a consensus target price of $2.00, suggesting a potential upside of 15.61%. Given Rockwell Medical's stronger consensus rating and higher probable upside, equities analysts plainly believe Rockwell Medical is more favorable than IRIDEX.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33IRIDEX 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Does the MarketBeat Community prefer RMTI or IRIX? Rockwell Medical received 36 more outperform votes than IRIDEX when rated by MarketBeat users. However, 65.54% of users gave IRIDEX an outperform vote while only 57.57% of users gave Rockwell Medical an outperform vote. CompanyUnderperformOutperformRockwell MedicalOutperform Votes30857.57% Underperform Votes22742.43% IRIDEXOutperform Votes27265.54% Underperform Votes14334.46% Which has preferable earnings & valuation, RMTI or IRIX? Rockwell Medical has higher revenue and earnings than IRIDEX. Rockwell Medical is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRockwell Medical$83.61M0.88-$8.44M-$0.05-45.40IRIDEX$51.87M0.55-$9.57M-$0.67-2.58 Do institutionals & insiders have more ownership in RMTI or IRIX? 23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 1.9% of Rockwell Medical shares are held by company insiders. Comparatively, 7.3% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, RMTI or IRIX? Rockwell Medical has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500. Comparatively, IRIDEX has a beta of 0.8, meaning that its stock price is 20% less volatile than the S&P 500. SummaryRockwell Medical beats IRIDEX on 16 of the 19 factors compared between the two stocks. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Get IRIDEX News Delivered to You Automatically Sign up to receive the latest news and ratings for IRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRIX vs. The Competition Export to ExcelMetricIRIDEXElectromedical equipment IndustryComputer SectorNASDAQ ExchangeMarket Cap$28.79M$3.52B$23.84B$8.80BDividend YieldN/A1.69%2.76%4.07%P/E Ratio-2.5812.07229.3613.60Price / Sales0.5592.553,404.3387.40Price / CashN/A47.0333.0636.27Price / Book10.813.946.816.33Net Income-$9.57M$92.21M$658.63M$225.93M7 Day Performance-2.26%-3.06%0.46%-0.96%1 Month Performance5.49%7.34%1.08%1.06%1 Year Performance-15.20%16.82%19.39%26.59% IRIDEX Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRIXIRIDEX0.6933 of 5 stars$1.73-0.6%$2.00+15.6%-17.1%$28.79M$51.87M-2.58120RMTIRockwell Medical4.1708 of 5 stars$2.23-4.3%$7.00+213.9%+19.5%$72.07M$83.61M-46.60300Analyst DowngradeTELATELA Bio3.7142 of 5 stars$2.89-0.3%$9.25+220.1%-40.5%$113.84M$58.45M0.00120FONRFONAR1.9718 of 5 stars$15.82+6.2%N/A-18.3%$100.14M$102.88M10.64480GUTSFractyl Health1.6229 of 5 stars$2.06flat$22.00+968.0%N/A$99.09M$120,000.00-0.17102EDAPEdap Tms2.4635 of 5 stars$2.62+6.9%$19.00+625.2%-45.7%$97.20M$65.42M-4.03307Analyst DowngradeLNSRLENSAR2.1545 of 5 stars$7.51+3.2%$8.00+6.5%+237.0%$87.19M$42.16M0.00110Positive NewsGap UpVANIVivani Medical3.1094 of 5 stars$1.30+0.8%$3.00+130.8%+35.6%$77.01MN/A0.0020MODDModular Medical3.0549 of 5 stars$2.06flat$5.00+142.7%+104.0%$71.21MN/A0.0039Positive NewsNSPRInspireMD2.5549 of 5 stars$2.60-1.5%$4.50+73.1%-4.0%$67.81M$6.20M0.0050Analyst ForecastMGRMMonogram Orthopaedics1.1098 of 5 stars$1.96-2.0%N/A-38.8%$67.25M$370,000.00-4.2628 Related Companies and Tools Related Companies RMTI Alternatives TELA Alternatives FONR Alternatives GUTS Alternatives EDAP Alternatives LNSR Alternatives VANI Alternatives MODD Alternatives NSPR Alternatives MGRM Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:IRIX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IRIDEX Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share IRIDEX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
